193 related articles for article (PubMed ID: 13677336)
21. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
22. Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy.
Santen RJ; Pinkerton J; McCartney C; Petroni GR
J Clin Endocrinol Metab; 2001 Jan; 86(1):16-23. PubMed ID: 11231971
[No Abstract] [Full Text] [Related]
23. Clinical trials report. Risks and benefits of hormone replacement therapy.
Kotchen TA; Mansour G; Mansour AJ
Curr Hypertens Rep; 2003 Dec; 5(6):483-4. PubMed ID: 14594567
[No Abstract] [Full Text] [Related]
24. Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin.
Colditz GA
Breast Cancer Res; 2007; 9(4):108. PubMed ID: 17666116
[TBL] [Abstract][Full Text] [Related]
25. Hormone therapy and breast cancer: the press-release version of WHI study data.
Pines A
Climacteric; 2013 Apr; 16(2):222-5. PubMed ID: 23488525
[No Abstract] [Full Text] [Related]
26. Hormone replacement and breast cancer. A remaining controversy?
Adami HO; Persson I
JAMA; 1995 Jul; 274(2):178-9. PubMed ID: 7596008
[No Abstract] [Full Text] [Related]
27. Estrogen-progestin increases breast cancer risk.
Stephens MB
J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
[No Abstract] [Full Text] [Related]
28. Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.
Shapiro S; deVilliers TJ; Pines A; Sturdee DW; Archer DF; Baber RJ; Panay N; Farmer RD; Stevenson JC; Mueck AO; Burger HG; Gompel A
J Natl Cancer Inst; 2014 Feb; 106(2):djt372. PubMed ID: 24363446
[No Abstract] [Full Text] [Related]
29. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk.
Rebbeck TR; Troxel AB; Shatalova EG; Blanchard R; Norman S; Bunin G; Demichele A; Schinnar R; Berlin JA; Strom BL
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1318-20. PubMed ID: 17548708
[No Abstract] [Full Text] [Related]
30. Breast cancer: the role of hormone therapy.
Creasman WT
Semin Reprod Med; 2005 May; 23(2):167-71. PubMed ID: 15852202
[TBL] [Abstract][Full Text] [Related]
31. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
Twombly R
J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368
[No Abstract] [Full Text] [Related]
32. Risk of breast cancer among users of estrogen plus progestogen and unopposed estrogen: is the likelihood of bias symmetrical?
Shapiro S
Climacteric; 2015 Jun; 18(3):333-5. PubMed ID: 25651904
[No Abstract] [Full Text] [Related]
33. Some comments on the Million Women Study.
Neves-E-Castro M
Climacteric; 2003 Dec; 6(4):357. PubMed ID: 15006258
[No Abstract] [Full Text] [Related]
34. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
von Schoultz B
Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
[No Abstract] [Full Text] [Related]
35. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
[TBL] [Abstract][Full Text] [Related]
36. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
Rollins G
Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
[No Abstract] [Full Text] [Related]
37. [Hormone replacement therapy and breast cancer].
Mueck AO
Med Monatsschr Pharm; 2002 Oct; 25(10):337-47. PubMed ID: 12404946
[No Abstract] [Full Text] [Related]
38. Critical review of the article by Colditz et al. on 'The use of estrogens and progestins and the risk of breast cancer in postmenopausal women' published in the N.E.J.M. 1995, 332: 1589.
Sismondi P; Biglia N
Pharmacol Res; 1995 Dec; 32(6):329-30. PubMed ID: 8736482
[No Abstract] [Full Text] [Related]
39. Estrogen replacement therapy and breast cancer.
Maguire PJ
J Reprod Med; 1993 Mar; 38(3):183-5. PubMed ID: 8487233
[TBL] [Abstract][Full Text] [Related]
40. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same].
Ribot C; Trémollieres F
Gynecol Obstet Fertil; 2007 May; 35(5):388-97. PubMed ID: 17392010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
